News Theranos settles with investor on claims it lied about busin... Partner Fund Management agrees to drop lawsuits.
News Health insurer spots potential of Owlstone's lung cancer bre... The venture capital arm of the UK’s biggest insurance firm Aviva is to invest $5 million (£4m) in Owlstone Medical, one of the country’s most promising and potentially groundbreaking diagno
News 'Repeated violations' behind Theranos lab closure CMS report describes failures meeting its own quality control procedures.
News Abbott’s Zika blood test approved for emergency use Abbott's test is now the first to receive FDA commercial authorisation in an emergency use setting.
News Roche enters blood diagnostic market, promises faster result... Platform combines morphology analysis, cell counting and cell classification.
News Second Theranos lab fails inspection, faces possibility of m... Sanctions could be imposed regardless of second lab closure.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
